Pancreas
The A.R.CA.D pancreas program gathers patient data relating to pancreatic cancer treatments. Therapeutic advances are urgently needed to combat pancreatic cancer. This group aims at expanding the pancreas database, which currently count over 8,500 entries.
A steering committee was appointed in 2020 – it includes 3 experts: Julien Taieb (Georges-Pompidou European Hospital), Jean Baptiste Bachet (Pitié-Salpêtrière Hospital) and Dewi Vernerey (CHU Besançon). Each member of this committee contributes to recovering datas – both from academic and industry – sponsored clinical trials.
The Methodology and Quality of Life in Cancerology Unit (UMQVC) team at Besançon University Hospital along with Morteza Raeisi, statistician at A.R.CA.D – carry out the analyses.
Conditions to integrate the ARCAD Pancreatic Group
The ARCAD Pancreatic Group is a diverse group, including world-renowned scientists who are experts in their field: oncologists, researchers, and statisticians.
To join the Group, one of the 2 following conditions must be filled:
I. to be involved in the steering committee of a published phase 3 or phase 2 randomized clinical trial and to help to the transfer of one or multiple trials on pancreatic cancer to the database
II.. to be a renowned scientist (oncologist, radiotherapist, surgeon, statistician) invited by the Steering Committee as member to join the Group in relation with help and work for the ARCAD pancreatic Database.
There is no formal membership to participate in the ARCAD Pancreas Database Project. The PIs of each trial or a selected collaborator are invited to join the group.
For any further information, please contact us